# Comparison of Antibiotics for Pseudomonas in Early CF

> **NCT00823238** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 21 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** ceftazidime and tobramycin
- **DRUG:** inhaled tobramycin

## Key facts

- **NCT ID:** NCT00823238
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2011-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823238, "Comparison of Antibiotics for Pseudomonas in Early CF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00823238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*